Cannara Announces Grant of Options and RSUs
Cannara Biotech (OTCQB: LOVFF), a vertically integrated cannabis producer with two mega facilities in Qu茅bec totaling over 1,650,000 sq. ft., has announced new incentive awards following its fiscal year-end on August 31, 2025.
The company granted 3,625,000 stock options to employees at an exercise price of $1.44 per share, vesting monthly over three years with a ten-year expiration. Additionally, 145,000 restricted share units (RSUs) were awarded to board members, vesting fully after two years. The announcement comes after five consecutive years of revenue growth in their cannabis operations.
Cannara Biotech (OTCQB: LOVFF), produttore di cannabis verticalmente integrato con due impianti di grandi dimensioni in Qu茅bec per un totale di oltre 1.650.000 piedi quadrati, ha annunciato nuove assegnazioni di incentivi dopo la chiusura dell'esercizio fiscale al 31 agosto 2025.
La societ脿 ha concesso 3.625.000 opzioni su azioni ai dipendenti a un prezzo di esercizio di $1,44 per azione, con vesting mensile per tre anni e scadenza a dieci anni. Inoltre, sono stati assegnati ai membri del consiglio 145.000 restricted share units (RSU), che matureranno totalmente dopo due anni. L'annuncio segue cinque anni consecutivi di crescita dei ricavi nelle loro attivit脿 legate alla cannabis.
Cannara Biotech (OTCQB: LOVFF), un productor de cannabis verticalmente integrado con dos instalaciones de gran tama帽o en Qu茅bec que suman m谩s de 1.650.000 pies cuadrados, ha anunciado nuevas concesiones de incentivos tras el cierre del ejercicio fiscal al 31 de agosto de 2025.
La compa帽铆a otorg贸 3.625.000 opciones sobre acciones a empleados con un precio de ejercicio de $1,44 por acci贸n, que se consolidan mensualmente durante tres a帽os y expiran a los diez a帽os. Adem谩s, se concedieron 145.000 restricted share units (RSU) a miembros del consejo, que se har谩n efectivas por completo despu茅s de dos a帽os. El anuncio se produce tras cinco a帽os consecutivos de crecimiento de ingresos en sus operaciones de cannabis.
Cannara Biotech (OTCQB: LOVFF)電� 韤橂病鞐� 齑� 1,650,000 韽夒癌頂柬姼臧� 雱橂姅 雽�順� 鞁滌劋 霊� 瓿踌潉 氤挫湢頃� 靾橃 韱淀暕順� 雽�毵�(旃鸽倶牍勳姢) 靸濎偘鞐呾泊搿�, 2025雲� 8鞗� 31鞚� 須岅硠鞐半弰 膦呺鞐� 霐半澕 靸堧鞖� 鞚胳劶韹半笇 靾橃棳毳� 氚滍憸頄堨姷雼堧嫟.
須岇偓電� 歆侅洂霌れ棎瓴� 頄夓偓 臧�瓴� 欤茧嫻 $1.44搿� 3,625,000欤�鞚� 鞀ろ啞鞓奠厴鞚� 攵�鞐枅鞙茧┌, 鞚措姅 3雲勳棎 瓯胳硱 鞗旊硠搿� 氩犾姢韺呺悩瓿� 毵岅赴電� 10雲勳瀰雼堧嫟. 霕愴暅 鞚挫偓須� 甑劚鞗愳棎瓴岆姅 145,000臧滌潣 鞝滍暅欤�(RSU)臧� 攵�鞐悩鞏� 2雲� 頉� 鞝勳暋 氩犾姢韺呺惄雼堧嫟. 鞚措矆 氚滍憸電� 旃鸽倶牍勳姢 靷梾鞐愳劀 5雲� 鞐办啀 毵れ稖 靹膘灔 鞚错泟鞐� 雮橃檾鞀惦媹雼�.
Cannara Biotech (OTCQB: LOVFF), producteur de cannabis int茅gr茅 verticalement disposant de deux m茅ga-installations au Qu茅bec totalisant plus de 1 650 000 pieds carr茅s, a annonc茅 de nouvelles attributions d'incitations apr猫s la cl么ture de l'exercice au 31 ao没t 2025.
La soci茅t茅 a octroy茅 3 625 000 options d'achat d'actions aux employ茅s 脿 un prix d'exercice de 1,44 $ par action, se consolidant mensuellement sur trois ans et expirant au bout de dix ans. De plus, 145 000 restricted share units (RSU) ont 茅t茅 attribu茅es aux administrateurs, qui seront enti猫rement acquises apr猫s deux ans. Cette annonce intervient apr猫s cinq ann茅es cons茅cutives de croissance des revenus dans leurs activit茅s li茅es au cannabis.
Cannara Biotech (OTCQB: LOVFF), ein vertikal integrierter Cannabisproduzent mit zwei Mega-Anlagen in Qu茅bec mit insgesamt 眉ber 1.650.000 Quadratfu脽, hat nach Abschluss des Gesch盲ftsjahres am 31. August 2025 neue Anreizzuteilungen angek眉ndigt.
Das Unternehmen gew盲hrte Mitarbeitern 3.625.000 Aktienoptionen zu einem Aus眉bungspreis von $1,44 pro Aktie, die monatlich 眉ber drei Jahre vesten und eine Laufzeit von zehn Jahren haben. Zus盲tzlich wurden dem Vorstand 145.000 Restricted Share Units (RSUs) zugesprochen, die nach zwei Jahren vollst盲ndig vesten. Die Ank眉ndigung erfolgt nach f眉nf aufeinanderfolgenden Jahren mit Umsatzwachstum im Cannabisgesch盲ft.
- Five consecutive years of year-over-year revenue growth
- Comprehensive employee and director incentive program implemented
- Large-scale operations with two mega facilities totaling 1,650,000 sq. ft.
- Potential dilution from 3,770,000 new shares through options and RSUs
MONTREAL, Sept. 01, 2025 (GLOBE NEWSWIRE) -- (鈥�Cannara鈥�, 鈥渢he Company鈥�, 鈥�us鈥� or 鈥�we鈥�) () () (), a vertically integrated producer of premium-grade cannabis products at disruptive prices with two mega facilities based in Qu茅bec spanning over 1,650,000聽sq. ft., today announced that its board of directors has approved the grant of incentive awards under the Company鈥檚 stock option plan (the 鈥�Stock Option Plan鈥�), and restricted share unit compensation plan (the 鈥�RSU Plan鈥�) (collectively, the 鈥�Incentive Plans鈥�).
The awards were granted aligning with the completion of the Company鈥檚 fiscal year-end on August 31, 2025, which marked five consecutive years of commercial operations and year-over-year revenue growth since launching its cannabis business.
In accordance with and subject to the terms of the Incentive Plans and the applicable requirements of the TSX Venture Exchange (the 鈥�TSXV鈥�), the Company has granted, effective August 28, 2025:
- 3,625,000 stock options to certain employees of the Company. Each stock option is exercisable into one common share of the Company at an exercise price of
$1.44 per share, will vest in equal monthly installments over a period of three (3) years, and will expire ten (10) years from the date of grant. - 145,000 restricted share units (RSUs) to members of the board of directors. Each RSU entitles the holder to receive one common share of the Company without additional consideration and will vest in full on the second anniversary of the date of grant.
The grants are subject to the terms of the Incentive Plans and the applicable requirements of the TSXV.
CONTACT
| Nicholas鈥疭osiak, CPA, CA Chief Financial Officer 苍颈肠办蔼肠补苍苍补谤补.肠补鈥� | 窜辞丑补谤鈥疜谤颈惫辞谤辞迟鈥� President & Chief Executive Officer鈥� 锄辞丑补谤蔼肠补苍苍补谤补.肠补鈥� |
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
ABOUT CANNARA
听() () (), is a vertically integrated producer of affordable premium-grade cannabis products for the Canadian markets. Cannara owns two mega facilities based in Qu茅bec spanning over 1,650,000聽sq. ft., providing the Company with 100,000聽kg of potential annualized cultivation output. Leveraging Qu茅bec鈥檚 low electricity costs, Cannara鈥檚 facilities produce premium-grade cannabis products at an affordable price. For more information, please visit鈥�.
FAQ
How many stock options did Cannara Biotech (LOVFF) grant in September 2025?
What is the vesting period for Cannara Biotech's 2025 RSU grants?
What is the size of Cannara Biotech's production facilities?
How long has Cannara Biotech been showing revenue growth?
